In Brief: Playtex
This article was originally published in The Tan Sheet
Executive Summary
Playtex: Looking to broaden OTC/H&BA portfolio through brand or company acquisitions, or by leveraging the Playtex name on new products in different categories, the company says. Hass, Wheat & Partners, which holds a 40% stake in Playtex, also is investigating strategic options for the company. The decision to further diversify may in part be a response to Procter & Gamble's April 9 announcement that it will acquire tampon category leader Tambrands. Playtex already is making headway in diversifying its revenue base -- for the first quarter of 1997, sun care (Banana Boat and BioSun) sales jumped 32.4% to $43.7 mil., representing 32% of the company's sales of $136.4 mil. The feminine care unit, on the other hand, slumped 32.7% to $39.1 mil., accounting for 28.7% of sales. In the year-earlier quarter, the segments represented 23.1% and 40.6% of sales, respectively...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning